Evidence map›Paper›PMID 37524763›Full record

ArticleScientific reports2023

Three-dimensional micro-X-ray topography using focused sheet-shaped X-ray beam.

Akio Yoneyama, Kotaro Ishiji, Atsushi Sakaki, Yutaka Kobayashi, Masayuki Inaba, Kazunori Fukuda, Kumiko Konishi, Akio Shima, Daiko Takamatsu

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Akio YoneyamaResearch and Development Group, Hitachi Ltd., 1-280 Higashi-Koigakubo, Kokubunji, 185-8601, Japan. yoneyama@saga-ls.jp.
Kotaro IshijiSAGA Light Source, 8-7 Yayoigaoka, Tosu, 841-0005, Japan.
Atsushi SakakiPhosphor R&D Center, Nichia Corporation, 1-19 Tatsumi, Anan, 774-0001, Japan.
Yutaka KobayashiChip Development Department, Nichia Corporation, 491 Oka, Kaminaka, Anan, 774-8601, Japan.
Masayuki InabaNissan ARC, Ltd. 1 Natsushima-Cho, Yokosuka, 237-0061, Japan.
Kazunori FukudaPhysical Analysis Center, Kobelco Research Institute, Inc., 1-5-5 Takatsukadai, Nishi-Ku, Kobe, 651-2271, Japan.
Kumiko KonishiResearch and Development Group, Hitachi Ltd., 1-280 Higashi-Koigakubo, Kokubunji, 185-8601, Japan.
Akio ShimaResearch and Development Group, Hitachi Ltd., 1-280 Higashi-Koigakubo, Kokubunji, 185-8601, Japan.
Daiko TakamatsuResearch and Development Group, Hitachi Ltd., 2520 Akanuma, Hatoyama, 350-0395, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

X-ray topography is a powerful method for analyzing crystal defects and strain in crystalline materials non-destructively. However, conventional X-ray topography uses simple X-ray diffraction images, which means depth information on defects and dislocations cannot be obtained. We have therefor developed a novel three-dimensional micro-X-ray topography technique (3D μ-XRT) that combines Bragg-case section topography with focused sheet-shaped X-rays. The depth resolution of the 3D μ-XRT depends mainly on the focused X-ray beam size and enables non-destructive observation of internal defects and dislocations with an accuracy on the order of 1 μm. The demonstrative observation of SiC power device chips showed that stacking faults, threading screw, threading edge, and basal plane dislocations were clearly visualized three-dimensionally with a depth accuracy of 1.3 μm. 3D μ-XRT is a promising new approach for highly sensitive and non-destructive analysis of material crystallinity in a three-dimensional manner.

Identifiers

PMID37524763
PMCPMC10390543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.